Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk

Circulation. 2007 Apr 24;115(16):2145-52. doi: 10.1161/CIRCULATIONAHA.106.662254. Epub 2007 Apr 9.

Abstract

Background: Current diagnostic thresholds for ambulatory blood pressure (ABP) mainly rely on statistical parameters derived from reference populations. We determined an outcome-driven reference frame for ABP measurement.

Methods and results: We performed 24-hour ABP monitoring in 5682 participants (mean age 59.0 years; 43.3% women) enrolled in prospective population studies in Copenhagen, Denmark; Noorderkempen, Belgium; Ohasama, Japan; and Uppsala, Sweden. In multivariate analyses, we determined ABP thresholds, which yielded 10-year cardiovascular risks similar to those associated with optimal (120/80 mm Hg), normal (130/85 mm Hg), and high (140/90 mm Hg) blood pressure on office measurement. Over 9.7 years (median), 814 cardiovascular end points occurred, including 377 strokes and 435 cardiac events. Systolic/diastolic thresholds for optimal ABP were 116.8/74.2 mm Hg for 24 hours, 121.6/78.9 mm Hg for daytime, and 100.9/65.3 mm Hg for nighttime. Corresponding thresholds for normal ABP were 123.9/76.8, 129.9/82.6, and 110.2/68.1 mm Hg, respectively, and those for ambulatory hypertension were 131.0/79.4, 138.2/86.4, and 119.5/70.8 mm Hg. After rounding, approximate thresholds for optimal ABP amounted to 115/75 mm Hg for 24 hours, 120/80 mm Hg for daytime, and 100/65 mm Hg for nighttime. Rounded thresholds for normal ABP were 125/75, 130/85, and 110/70 mm Hg, respectively, and those for ambulatory hypertension were 130/80, 140/85, and 120/70 mm Hg.

Conclusions: Population-based outcome-driven thresholds for optimal and normal ABP are lower than those currently proposed by hypertension guidelines.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Alcohol Drinking / epidemiology
  • Antihypertensive Agents / therapeutic use
  • Auscultation
  • Belgium / epidemiology
  • Blood Pressure Monitoring, Ambulatory* / instrumentation
  • Blood Pressure Monitoring, Ambulatory* / methods
  • Body Mass Index
  • Cardiovascular Diseases / epidemiology*
  • Circadian Rhythm
  • Cohort Studies
  • Confounding Factors, Epidemiologic
  • Coronary Disease / epidemiology
  • Death, Sudden, Cardiac / epidemiology
  • Denmark / epidemiology
  • Diabetes Mellitus / epidemiology
  • Dyslipidemias / epidemiology
  • Female
  • Heart Failure / epidemiology
  • Heart Failure / etiology
  • Humans
  • Hypertension / diagnosis*
  • Hypertension / drug therapy
  • Hypertension / epidemiology
  • Hypertension / physiopathology
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Myocardial Ischemia / mortality
  • Myocardial Revascularization / statistics & numerical data
  • Oscillometry
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Prospective Studies
  • Reference Values
  • Reproducibility of Results
  • Risk Factors
  • Smoking / epidemiology
  • Sphygmomanometers / classification
  • Stroke / epidemiology
  • Sweden / epidemiology

Substances

  • Antihypertensive Agents